Filter Results
:
(5,309)
Show Results For
-
All HBS Web
(5,309)
- People (17)
- News (1,927)
- Research (2,575)
- Events (4)
- Multimedia (203)
- Faculty Publications (1,868)
Show Results For
-
All HBS Web
(5,309)
- People (17)
- News (1,927)
- Research (2,575)
- Events (4)
- Multimedia (203)
- Faculty Publications (1,868)
- August 2015 (Revised August 2015)
- Case
Hoag Orthopedic Institute
By: Robert S. Kaplan and Jonathan Warsh
Two groups of orthopedic surgeons form a joint venture with a community hospital to establish Hoag Orthopedic Institute, a for-profit hospital and two ambulatory service centers. By controlling and integrating all aspects of the patients' medical treatment, the...
View Details
Keywords:
Outcomes Measurement;
Bundled Payment;
Health Care;
Activity-based Costing And Management;
Measurement and Metrics;
Activity Based Costing and Management;
Competitive Strategy;
Medical Specialties;
Health Care and Treatment;
Outcome or Result;
Health Industry
Kaplan, Robert S., and Jonathan Warsh. "Hoag Orthopedic Institute." Harvard Business School Case 115-023, August 2015. (Revised August 2015.)
- December 2013 (Revised May 2021)
- Case
Paul Levy: Confronting a 'Corporate Campaign' (A)
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a...
View Details
Keywords:
Dispute Resolution;
Corporate Campaign;
Negotiating Campaign;
Bargaining;
Health Care;
Hospitals;
Unions;
Health Care and Treatment;
Negotiation;
Strategy;
Negotiation Process;
Labor Unions;
Health Industry;
Boston
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
- Article
Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth
By: Leemore S. Dafny, Igal Hendel, Victoria Marone and Christopher Ody
Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance Marketplaces. At the same time, Marketplace premiums in the period 2014–2016 were much lower than projected by the Congressional...
View Details
Dafny, Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody. "Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth." Health Affairs 36, no. 9 (September 2017).
- October 2013 (Revised January 2015)
- Case
The Slingshot: Improving Water Access
By: John A. Quelch, Margaret L. Rodriguez and Carin-Isabel Knoop
In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to...
View Details
Keywords:
Water;
Public Health;
Health Care;
Slingshot;
Dean Kamen;
DEKA;
Coca-Cola;
Developing Markets;
Freestyle;
Safety;
Natural Environment;
Pollutants;
Health;
Distribution Channels;
Developing Countries and Economies;
Innovation and Invention;
Africa;
Latin America;
South America;
Asia
Quelch, John A., Margaret L. Rodriguez, and Carin-Isabel Knoop. "The Slingshot: Improving Water Access." Harvard Business School Case 514-007, October 2013. (Revised January 2015.)
- 28 Sep 2020
- News
Some Workers Face Looming Cutoffs in Health Insurance
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby...
View Details
Keywords:
Health Care;
Biosimilars;
Biologics;
Pharmaceutical Competition;
Healthcare Spending;
Innovation;
Health Care and Treatment;
Spending;
Market Entry and Exit;
Competition;
Innovation and Invention;
Pharmaceutical Industry;
United States;
Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- 01 Jul 2007
- News
Redefining Health Care: Creating Value-based Competition on Results
- Article
Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected
By: Maximilian J. Pany, Michael E. Chernew and Leemore S. Dafny
Concern about high hospital prices for commercially insured patients has motivated several proposals to regulate these prices. Such proposals often limit regulations to highly concentrated hospital markets. Using a large sample of 2017 US commercial insurance claims,...
View Details
Keywords:
Health Care Providers;
Hospitals;
Insurance Market Regulation;
Price Regulation;
Markets;
Health Care and Treatment;
Cost;
Quality;
Insurance;
Price;
Governing Rules, Regulations, and Reforms
Pany, Maximilian J., Michael E. Chernew, and Leemore S. Dafny. "Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected." Health Affairs 40, no. 9 (September 2021): 1386–1394.
- September 2023
- Teaching Note
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
Teaching Note for HBS Case No. 304-009. The case is part of the first module of the Innovating in Health Care course. Its purpose is to demonstrate how to evaluate the “do good” and do well” potential of a health care innovation.
View Details
- August 2012 (Revised August 2014)
- Case
Cancer Treatment Centers of America® (A)
By: Regina E. Herzlinger and Natalie Kindred
Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who...
View Details
Keywords:
Cancer;
Cancer Treatment;
Health Care;
Healthcare;
Accountability;
Outcomes;
Outcomes Measurement;
Outcomes Reporting;
Hub And Spoke Cancer Care;
Hub And Spoke;
Hub-and-spoke;
Focused Factory;
Mission and Purpose;
Private Ownership;
For-Profit Firms;
Health Disorders;
Medical Specialties;
Policy;
Business Model;
Expansion;
Decision Choices and Conditions;
Advertising;
Health Care and Treatment;
Innovation and Invention;
Health Industry;
United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
- November–December 2015
- Article
Active Postmarketing Drug Surveillance for Multiple Adverse Events
By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical...
View Details
Keywords:
Drug Surveillance;
Health Care;
Stochastic Models;
Queueing;
Diffusion Approximation;
Brownian Motion;
Health Care and Treatment;
Analytics and Data Science;
Analysis
Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios. "Active Postmarketing Drug Surveillance for Multiple Adverse Events." Operations Research 63, no. 6 (November–December 2015): 1528–1546. (Finalist, 2012 INFORMS Health Applications Society Pierskalla Award.)
- 02 Jan 2020
- News
Medicare for All or Public Option: Can Either Heal Health Care?
- April 2000
- Teaching Note
Patient Care Delivery Model at the Massachusetts General Hospital, The TN
By: Amy C. Edmondson, Richard M.J. Bohmer and Emily Heaphy
Teaching Note for (9-699-154).
View Details
- 12 Oct 2015
- News
Google Ventures: Big-time Consumer Health Is Still a Dream
- Research Summary
Overview
Phil's work aims to identify the drivers of performance for healthcare organizations and providers, and the mechanisms by which this performance can change over time. In complex healthcare settings, the optimal choice of treatment can be highly ambiguous. As a...
View Details
- 22 Jul 2014
- News
To Fix Health Care, Let Go of the Status Quo
- March 2010
- Teaching Note
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)
By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078].
View Details